in Resignations

Dova Pharmaceuticals CFO Doug Blankenship Resigned

0 Comments

Dova Pharmaceuticals Announces the Appointment of Mark W. Hahn as Chief Financial Officer

DURHAM, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) — Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced the appointment of Mark W. Hahn as the …

Name: Doug Blankenship

Continent: North America

Country: USA

Company: Dova Pharmaceuticals

Branch: Pharma

Position: CFO

Reason: Resigned

Announcement Date: January 29, 2018, 11:00pm

Resignation Date: January 29, 2018, 11:00pm

Source 1: http://markets.businessinsider.com/news/stocks/Dova-Pharmaceuticals-Announces-the-Appointment-of-Mark-W-Hahn-as-Chief-Financial-Officer-1014549104

Add your submission

Image Video Audio Text Embed

This field is required
Delete

Drop Images Here

or

You don't have javascript enabled. Media upload is not possible.

Get image from URL

Maximum upload file size: 10 MB.

Processing...

This field is required Learn more

This field is required
Delete

Drop Video Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://www.youtube.com/watch?v=WwoKkq685Hk

Add

Supported services:

Maximum upload file size: 20 MB.

Processing...

This field is required Learn more

This field is required
Delete

Drop Audio Here

or

You don't have javascript enabled. Media upload is not possible.

e.g.: https://soundcloud.com/community/fellowship-wrapup

Add

Supported services:

Maximum upload file size: 150 MB.

Processing...

This field is required Learn more

This field is required Learn more

This field is required
Delete

e.g.: https://www.youtube.com/watch?v=DWYrcnehito

Supported services:

Processing...

This field is required Learn more

Report

CFODoug BlankenshipDova PharmaceuticalsNorth AmericaPharmaResignedUSA

What do you think?

0 points

Leave a Reply